Antibiotic resistance

Dental Clinics of North America

Volumn 47, Issue 4, 2003, Pages 623-639

  Pallasch, Thomas J ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b VA 22304 8668 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFRADINE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CLARITHROMYCIN; CLINDAMYCIN; ERYTHROMYCIN; MACROLIDE; METICILLIN; METRONIDAZOLE; OXACILLIN; PENICILLIN G; SULFONAMIDE; TETRACYCLINE; TETRACYCLINE DERIVATIVE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; CHROMOSOME ABERRATION; DRUG HYPERSENSITIVITY; DRUG MECHANISM; GENE EXPRESSION; GENE TRANSFER; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; MOUTH CAVITY; MOUTH INFECTION; NONHUMAN; POSTOPERATIVE INFECTION; REVIEW; RHEUMATIC FEVER; SIDE EFFECT; STREPTOCOCCUS; STREPTOCOCCUS INFECTION; SUPERINFECTION;

ANTI-BACTERIAL AGENTS; BACTERIA; BACTERIAL INFECTIONS; CONJUGATION, GENETIC; DENTISTRY; DRUG RESISTANCE, MICROBIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; MOUTH DISEASES; PRESCRIPTIONS, DRUG;

EID: 3242743708     PISSN: 00118532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-8532(03)00039-9     Document Type: Review

References (75)

1. McDermott W., Rogers D.E. Social ramifications of control of microbial diseases. Johns Hopkins Med J. 151:(6):1982;302-312
2. Cohen M.L. Changing patterns of infectious disease. Nature. 406:(6797):2000;762-767
3. Pittet D., Tarara D., Wenzel R.P. Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality. JAMA. 271:(20):1994;1598-1601
4. Pinner R.W., Teutsch S.M., Simonsen L., et al. Trends in infectious diseases mortality in the United States. JAMA. 275:(3):1996;189-193
5. Wenzel R.P., Edmond M.B. The impact of hospital-acquired bloodstream infections. Emerg Infect Dis. 7:(2):2001;174-177
6. Tomasz A. Multiple-antibiotic-resistant pathogenic bacteria-a report on the Rockefeller University Workshop. N Engl J Med. 330:(17):1994;1247-1251
7. Centers for Disease Control and Prevention. Staphylococcus aureus resistant to vancomycin in United States. MMWR. 51:(26):2002;565-567
8. Bonomo R.A. Multiple antibiotic-resistant bacteria in long-term-care facilities: an emerging problem in the practice of infectious diseases. Clin Infect Dis. 31:(6):2000;1414-1422
9. Holmes S.J., Morrow A.L., Pickering L.K. Child care practices: effects of social changes on the epidemiology of infectious diseases and antibiotic resistance. Epidemiol Rev. 18:(1):1996;10-28
10. Herold B.C., Immergluck L.C., Maranan M.C., et al. Community-acquired methicillin-resistant Staphylococcus aureus in children with no predisposing risk. JAMA. 279:(8):1998;593-598
11. Centers for Disease Control and Prevention. Outbreaks of Escherichia coli 0157:H7 infections among children associated with farm visits - Pennsylvania and Washington, 2000. MMWR. 50:(15):2001;293-297
12. Pallasch T.J. Global antibiotic resistance and its impact on the dental community. Calif Dent Assn J. 28:(3):2000;215-233
13. Rocha P., Baleerio C., Tunkel A.R. Impact of antimicrobial resistance on the treatment of invasive pneumococcal infections. Curr Infect Dis Report. 2:(5):2000;399-408
14. Hoban D.J., Doern G.V., Fluit M.C., et al. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis. 32:(S2):2001;S89-S93
15. Lynch J.P. III, Martinez F.J. Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia. Clin Infect Dis. 34:(S1):2002;S37-S46
16. Chang S.-C., Chen Y.-C., Luh K.T., Hsieh W.C. Macrolide resistance of common bacteria isolated from Taiwan. Diagn Microbiol Infect Dis. 23:(4):1995;147-154
17. Edmond M.B., Wallace S.E., McClish D.K., Pfaller M.A., Jones R.N., Wenzel R.P. Nosocomial bloodstream infections in the United States hospitals: a three-year analysis. Clin Infect Dis. 29:(2):1999;239-244
18. Low D.E., Keller N., Barth A., Jones R.N. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns to enterococci; results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin Infect Dis. 32:(S2):2001;S133-S145
19. Meyer J.M., Silliman N.P., Wang W., et al. Risk factors for Helicobacter pylori resistance in the United States: the Surveillance of H. pylori Antimicrobial Resistance Partnership (SHARP) Study, 1993-1999. Ann Intern Med. 136:(1):2002;13-24
20. Gerrits M.M., Dezoete M.R., Arents N.L.A., Kuipers E.J., Kusters J.G. 16SrRNA mutation-mediated tetracycline resistance in Helicobacter pylori. Antimicrob Agents Chemother. 46:(9):2002;2996-3000
21. Farber B.F., Eliopoulos G.M.N., Ward J.L., et al. Multiply resistant viridans group streptococcus susceptibility β-lactam antibiotics and comparison of penicillin-binding proteins. Antimicrob Agents Chemother. 24:(50):1983;702-705
22. Erickson P.R., Herzberg M.C. Emergence of antibiotic resistant Streptococcus sanguis in dental plaque of children after frequent antibiotic therapy. Pediatr Dent. 21:(3):1999;181-185
23. Nishi J.I., Yoshinaga M., Nomura Y. Prevalence of penicillin-resistant viridans streptococci in the oral flora of Japanese children at risk for endocarditis. Circulation. 99:(9):1999;1274-1275
24. Jones R.N., Wilson W.R. Epidemiology, laboratory detection, and therapy of penicillin-resistant streptococcal infections. Diagn Microbiol Infect Dis. 31:(3):1998;453-459
25. Doern G.V., Ferraro M.J., Brueggeman A.B., Ruoff K.L. Emergence of high rates of antimicrobial resistance among viridans group streptococci in the United States. Antimicrob Agents Chemother. 40:(4):1996;891-894
26. Reinert R.R., Von Eiff C., Kresken M., et al. Nationwide German multicenter study on the prevalence of antibiotic resistance in streptococcal blood isolates from neutropenic patients and comparative in vitro activities of quinupristin/dalfopristin and eight other antibiotics. J Clin Microbiol. 39:(5):2001;1928-1931
27. Tunkel A.R., Sepkowitz K.A. Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis. 34:(11):2002;1524-1529
28. Doern G.V. Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. Clin Infect Dis. 33:(S3):2001;S187-S192
29. Thornsberry C., Sahm D.F., Kelly L.T., et al. Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000. Clin Infect Dis. 34:(S1):2002;S4-S16
30. Herrera D., van Winkelhoff A.J., Dellemijn-Kippuw N., Winkel E.G., Sanz M. Beta-lactamase producing bacteria in the subgingival flora of adult patients with periodontitis: a comparison between Spain and The Netherlands. J Clin Periodontol. 27:(7):2000;520-525
31. Nyfors S., Kononen T., Takal A., Jousimies-Somer H. Beta-lactamase production by oral anaerobic gram-negative species in infants in relation to previous antimicrobial therapy. Antimicrob Agents Chemother. 43:(7):1999;1591-1594
32. King A., Bathgate T., Phillips I. Erythromycin susceptibility of viridans streptococci from normal throat flora of patients treated with azithromycin or clarithromycin. Clin Microbiol Infect Dis. 8:(2):2002;85-92
33. Gershon A.S., deAzavedo J.C.S., McGeer A., et al. Activities of new fluoroquinolones, ketolides, and other antimicrobials against blood culture isolates of viridans group streptococci from across Canada, 2000. Antimicrob Agents Chemother. 46:(5):2002;1553-1556
34. Gordon K.A., Beach M.L., Biedenbach D.J., et al. Antimicrobial susceptibility patterns of beta-hemolytic and viridans group streptococci: report from the SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis. 43:(2):2002;157-162
35. Suzuki J., Komatsuzawa H., Sugai M., et al. A long-term survey of methicillin-resistant Staphylococcus aureus in the oral cavity of children. Microbiol Immunol. 41:(9):1997;681-686
36. Walker C.B. The acquisition of antibiotic resistance in the periodontal microflora. Periodontology 2000. 10:1996;79-88
37. Arber W. Genetic variations: molecular mechanisms and impact on microbial evolution. FEMS Microbiol Rev. 24:(1):2000;1-7
38. Andrup L. Conjugation in gram-positive bacteria and kinetics of plasmid transfer. APMIS. 106:(S84):1998;S47-S55
39. Havarstein L.S. Bacterial gene transfer by natural genetic biotransformation. APMIS. 106:(S84):1998;S84-S55
40. Mahillin J. Transposons as gene haulers. APMIS. 106:(S84):1998;S29-S36
41. Rice L.B. Bacterial monopolists: the bundling and dissemination of resistance genes in gram-positive bacteria. Clin Infect Dis. 31:(3):2000;762-769
42. Ploy M.C., Lambert T., Couty J.-P., Denis F. Integrons: an antibiotic resistance gene capture and expression system. Clin Chem Lab Med. 38:(6):2000;483-487
43. Fluit A.C., Schmitz F.J. Class I integrons, gene cassettes, mobility, and epidemiology. Eur J Clin Microbiol Infect Dis. 18:(11):1999;761-770
44. Rowe-Magnus D.A., Guerout A.-M., Mazel D. Bacterial resistance evolution by recruitment of super-integron gene cassettes. Mol Microbiol. 43:(6):2002;1657-1669
45. Barbosa T.M., Levy S.B. The impact of antibiotic use in resistance development and resistance. Drug Resist Updat. 2000;303-311
46. Levy S.B. The antibiotic paradox: how the misuse of antibiotics destroys their curative powers. 2nd edition:2002;Perseus, Cambridge, MA
47. Guillemot D, Carbon C, Balkau B et al. Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA 279(5):365-70.
48. Kaye K.S., Kay D. Multidrug-resistant pathogens: mechanisms of resistance and epidemiology. Curr Infect Dis Report. 2:2000;391-398
49. Koch A.L. Penicillin binding proteins, beta-lactams, and lactamases: offensives, attacks and defensive countermeasures. Crit Rev Microbiol. 26:(4):2000;205-220
50. Walsh C. Molecular mechanisms that confer antimicrobial drug resistance. Nature. 406:(6797):2000;775-781
51. Hackenbeck R., Kaminski K., Konig A., et al. Penicillin-binding proteins in beta-lactam resistant Streptococcus pneumoniae. Microb Drug Resist. 5:1999;91-99
52. Levison M.E., Mallela S. Increasing antimicrobial resistance: therapeutic implications for enterococcal infections. Curr Infect Dis Report. 2:2000;417-423
53. Van Bembeke F., Balzi E., Tulkeas P.M. Antibiotic efflux pumps. Biochem Pharmacol. 60:(4):2000;457-470
54. Nikaido H. Multiple antibiotic resistance and efflux. Curr Opin Microbiol. 1:(5):1998;516-523
55. Putman M., van Veen H.W., Konigs W.N. Molecular properties of bacterial multidrug transporters. Microbiol Mol Biol Rev. 64:(4):2000;672-693
56. Verdier L., Gharbi-Benarous J., Bertho G., Mauvais P., Girault J.-P. Antibiotic resistance peptides: interaction of peptides conferring macrolide and ketolide resistance with Staphylococcus aureus ribosomes: conformation of bound peptides as determined by transferred NOE experiments. Biochemistry. 41:(13):2002;4218-4229
57. Charpentier E., Tuomanen E. Mechanisms of antibiotic resistance and tolerance in Streptococcus pneumoniae. Microbes Infect. 2:(15):2000;1855-1864
58. Chopra I., Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol Mol Biol Rev. 65:(2):2001;232-260
59. Summers A.O., Wireman J., Vimy M.J., et al. Mercury released from dental "silver" fillings provokes an increase in mercury- and-antibiotic-resistant bacteria in oral and intestinal floras of primates. Antimicrob Agents Chemother. 37:(4):1993;825-834
60. Wireman J., Liebert C.A., Smith T., Summers A.O. Association of mercury resistance with antibiotic resistance in gram-negative fecal bacteria in primates. Appl Environ Microbiol. 63:(11):1997;4494-4503
61. Leistevuo T., Jarvinen H., Osterblad M., Leistevuo T., Huovinen P., Tenovuo J. Resistance to mercury and antimicrobial agents in Streptococcus mutans isolates from human subjects in relation to exposure to dental amalgam fillings. Antimicrob Agents Chemother. 44:(2):2000;456-457
62. Osterblad M., Leistevuo J., Leistevuo T., et al. Antimicrobial and mercury resistance in aerobic gram-negative bacilli in fecal flora among persons with and without dental amalgam fillings. Antimicrob Agents Chemother. 39:(11):1995;2499-2502
63. Pike R., Lucas V., Stapleton P., et al. Prevalence and antibiotic resistance profile of mercury-resistant oral bacteria from children with and without mercury amalgam fillings. J Antimicrob Chemother. 49:(5):2002;777-783
64. Galperin M.Y., Koonin E.V. Searching for drug targets in microbial genomes. Curr Opin Biotechnol. 10:(6):1999;571-578
65. Sulakvelidze A., Alavidze Z., Morris J.G. Jr. Bacteriophage therapy. Antimicrob Agents Chemother. 45:(3):2001;649-659
66. Breithaupt H. The new antibiotics: can novel antibacterial treatments combat the rising tide of drug-resistant infections? Nat Biotechnol. 17:(12):1999;1165-1169
67. Miller M.B., Bassler B.L. Quorum sensing in bacteria. Annu Rev Microbiol. 55:2001;165-169
68. Thomas J., Walker C., Bradshaw M. Long-term use of subantimicrobial dose of doxycycline does not lead to changes in antimicrobial susceptibility. J Periodontol. 71:(9):2000;1472-1483
69. Cleveland J.I., Kohn W.C. Antimicrobial resistance and dental care: a CDC perspective. Dent Abstr. 1998;108-110
70. Palmer N.O.A., Martin M.V., Pealing R. An analysis of antibiotic prescriptions from general dental practitioners in England. J Antimicrob Chemother. 46:(6):2000;1033-1035
71. Epstein J.B., Chong S., Le N.D. A survey of antibiotic use in dentistry. J Am Dent Assoc. 131:(11):2000;1600-1609
72. Yingling NM, Byrne EB, Hartwell GR Antibiotic use by members of the American Academy of Endodontists in the year 2000: report of a national survey. 2002;28(5):396-404.
73. Pallasch T.J. Pharmacokinetic principles of antimicrobial therapy. Periodontology 2000. 1996;5-11
74. Martin M.V., Longman L.P., Hill J.B., Hardy P. Acute dentoalveolar infections: an investigation of the duration of antibiotic therapy. Br Dent J. 183:(4):1997;135-137
75. Hessen M.T., Kaye D. Principles of selection and use of antibacterial agents: in vitro activity and pharmacology. Infect Dis Clin North Am. 14:(2):2000;265-279